Sponsor pipeline

Hemab ApS clinical trial pipeline

Get alerts when Hemab ApS's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
1
Phase 1/2
2
Phase 2
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07347249 A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency Congenital Factor VII Deficiency Recruiting 2026-07-22
Phase 1/2
NCT06754852 A Study Assessing HMB-002 in Participants With Von Willebrand Disease Von Willebrand Disease (VWD) Recruiting 2026-06-30
NCT06211634 A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics… Glanzmann Thrombasthenia Active, Not Recruiting 2026-09-25
Phase 1
NCT07798505 A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of… Healthy Adult Participants Recruiting 2026-09-10
Not specified
NCT06610201 A Study of Bleeding and Treatment in Participants With Von Willebrand Disease Von Willebrand Disease (VWD) Recruiting 2026-04-21
Get alerts when Hemab ApS's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free